bibliographic entry 11623225 [be/11623225]
https://w3id.org/oc/corpus/be/11623225

is a

• bibliographic reference

content

• Washam JB, Stevens SR, Lokhnygina Y, et al. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Lancet 2015; 385: 2363-70. PMID: 25749644

references

• https://w3id.org/oc/corpus/br/4338650